PD64-05 THE UBIQUITIN-PROTEASOME PATHWAY VIA NPL4 SUPPRESSION IS A PROMISING THERAPEUTIC TARGET IN CLEAR CELL RENAL CELL CARCINOMA

INTRODUCTION AND OBJECTIVE:Molecular targeted drugs that can inhibit vascular endothelial growth factor receptor (VEGFR), mammalian target of rapamycin (mTOR), or programmed cell death 1 (PD-1) hav...